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Experimental allergic encephalomyelitis (EAE) is an ani-
mal model of multiple sclerosis that is induced by immuni-
zation with myelin antigens (1). The ability to generate
EAE by activating myelin-specific T cells in the periphery
of healthy animals demonstrates that central and peripheral
mechanisms of tolerance are incomplete for these self-anti-
gens. This lack of T cell tolerance toward myelin proteins
was initially thought to be due to restricted expression of
these antigens behind the blood–brain barrier. Recent data
demonstrate that T cell epitopes from the two most abun-
dant proteins in myelin, proteolipid protein (PLP) and my-
elin basic protein (MBP), are expressed not only within the
central nervous system (CNS) and peripheral nervous sys-
tem but within the thymus, spleen, and lymph nodes as
well (2–6).
In this issue of 
 
The
 
 
 
Journal of Experimental Medicine
 
 (7), as
well as in a related paper in 
 
Nature Medicine
 
 (8), the ques-
tion of whether PLP expression in the thymus shapes the
PLP-specific TCR repertoire is explored. PLP exists in two
isoforms: PLP is the full-length form, and DM20 is a
shorter form generated by alternative splicing that lacks 35
amino acids (9). Although transcripts corresponding to
both isoforms are detected in the thymus, Anderson et al.
(7) and Klein et al. (8) report that the DM20 transcript is
expressed intrathymically at much higher levels than the
full-length PLP transcript. These findings suggest that de-
terminants within DM20 may be much more effective at
inducing central tolerance than determinants found only in
the larger form of PLP.
Klein et al. demonstrate that T cells specific for several
determinants that are shared between PLP and the DM20
do indeed undergo tolerance in wild-type mice. Using thy-
mic grafts and bone marrow chimeras, they show that both
thymic epithelial cells and bone marrow–derived cells me-
diate tolerance induction in PLP-specific T cells. Anderson
et al. make the striking observation that T cells specific for
a determinant that is unique to the larger form of PLP and
missing from DM20 (PLP 139–151) are not tolerized in
SJL mice. Both groups conclude that the level of thymic
expression of DM20 is sufficient to mediate tolerance to
epitopes in this isoform but that thymic expression of PLP
is not sufficient to induce tolerance to the unique se-
quences in the PLP isoform. The ability to detect responses
to PLP 139–151 in lymph node cells from SJL mice indi-
cates that these T cells not only escape central tolerance but
escape peripheral tolerance as well.
Interestingly, studies of tolerance to MBP provide a dif-
ferent perspective on central tolerance to CNS antigens.
Like PLP transcripts, MBP transcripts have been detected
in the thymus and other lymphoid organs (3, 6, 10). This
occurs because the MBP gene complex contains two strong
promoters, each of which initiates a family of alternatively
spliced transcripts (2). One family encodes isoforms of clas-
sic MBP contained in myelin. The other family encodes
isoforms called golli-MBP. These transcripts contain unique
exons, as well as many (but not all) of the exons of classic
MBP. Golli-MBP transcripts are expressed in the thymus
and peripheral lymphoid tissues, whereas expression of clas-
sic MBP transcripts appears to be restricted to myelin-
forming cells (10–12). This differential expression pattern
suggests that epitopes in golli-MBP could induce central
tolerance, but epitopes contained exclusively in classic MBP
would not be available to induce tolerance in the thymus.
This prediction was fulfilled in C3H mice (13, 14), but,
surprisingly, this correlation was not observed in B10.PL
mice (15).
A comparison of the immune response to MBP in wild-
type and MBP-deficient B10.PL mice revealed that T cells
specific for two epitopes within MBP 121–150 undergo
strong tolerance induction, whereas T cells specific for
MBP 1–11 are not tolerized (15). MBP 1–11 
 
is
 
 contained
in the golli-MBP transcripts expressed in the thymus,
whereas MBP 121–150 
 
is not
 
 contained in these transcripts.
Sequences corresponding to the MBP 121–150 region
have not been detected by PCR in the thymus, and no
cDNA clones generated from thymus RNA have been re-
ported to contain MBP 121–150 sequences (10, 16). Thus,
tolerance to MBP epitopes is not correlated with the syn-
thesis of these sequences in the thymus.
The differential tolerance to MBP epitopes in B10.PL
mice correlates with the stability of the MBP peptide–
MHC complexes. MBP 1–11 forms very unstable com-
plexes with MHC molecules that do not appear to be
effective in mediating central tolerance, whereas both
epitopes in MBP 121–150 form extremely stable com-
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plexes (15, 17, 18). To study the mechanisms and site of
tolerance induction to MBP, we have generated TCR-
transgenic mice specific for MBP 121–150 epitopes. Unex-
pectedly, this model shows that extensive deletion of MBP
121–150-specific T cells occurs in the thymus (Huseby, E.,
and J. Goverman, manuscript in preparation). These data
demonstrate that central tolerance to MBP epitopes can oc-
cur in the absence of synthesis of these epitopes in the thy-
mus. It is possible that the very high stability of MBP 121–
150–MHC complexes allows bone marrow–derived cells
to transport sufficient amounts of these complexes to the
thymus to induce central tolerance.
The observation that protein synthesis within the thymus
is not a requirement for central tolerance to high-affinity
MBP epitopes raises the question of why PLP 139–151-spe-
cific T cells are not tolerized in a fashion similar to MBP
121–150-specific T cells. One possibility is that the affinity of
the PLP 139–151-specific TCRs is lower for their ligand
than the affinity of MBP 121–150-specific TCRs. The affin-
ities of the TCRs have not been measured in either system.
However, the MBP 1–11- and MBP 121–150-specific T
cells differ only 10-fold in the amount of antigen required
for half-maximal stimulation, suggesting that MBP 121–150-
specific TCRs do not have unusually high affinity. A more
likely explanation is that the high stability of the MBP 121–
150–I-A
 
u
 
 complexes allows APCs that have internalized
MBP to retain these complexes on the cell surface while mi-
grating to sites of tolerance induction. The PLP 139–151
epitope is also reported to have high affinity for I-A
 
s
 
 (19);
however, it may not be comparable to the affinity of MBP
121–150 for I-A
 
u
 
. A third explanation, for which no data are
yet available, is that MBP may be preferentially internalized
and processed by APCs in the periphery relative to PLP.
The studies by Anderson et al. (7) of PLP-specific T cells
yielded another surprising finding. In SJL and Balb.S mice,
which are both very susceptible to induction of EAE,
Anderson et al. find a very high precursor frequency (
 
z
 
1/
40,000) of peripheral PLP 139–151-specific T cells. B10.S
mice that are more resistant to EAE exhibit a somewhat
lower precursor frequency of PLP 139–151-specific T cells.
The authors observe that PLP-specific T cells were pre-
dominantly found in the CD44
 
hi
 
 subset of peripheral T
cells in SJL mice and suggest that these cells undergo ex-
pansion in the periphery. The high frequency of peripheral
PLP 139–151-specific T cells was also found in PLP-defi-
cient and germ-free mice, suggesting that these cells are ex-
panded in the periphery by interactions with a cross-reac-
tive self-antigen. This interaction did not appear to trigger
the T cells to differentiate, however, because they pro-
duced cytokines consistent with a Th0 phenotype when
stimulated with PLP 139–151 in vitro. The preliminary
phenotype described for these PLP-specific T cells is con-
sistent with the “central memory” T cell subset described
by Sallusto et al. (20).
The studies of Anderson et al. raise a key question: why
don’t mice that have such a remarkably high precursor fre-
quency of nontolerized T cells specific for a myelin antigen
develop spontaneous EAE? To understand why self-reac-
tive T cells fail to cause autoimmunity, it is useful to think
about the steps that are required for the pathogenesis of au-
toimmune disease. First, autoreactive T cells must be posi-
tively selected in the thymus and migrate to the periphery.
Opposing this step is induction of tolerance during T cell
maturation in the thymus (21, 22). Next, autoreactive T
cells that escape central tolerance are primed by antigen in
the periphery such that they differentiate into effector T
cells. If the expression of the self-antigen in the periphery is
too low to initiate interactions with T cells, the T cells will
not proceed further along the pathway and remain in a
state of ignorance (23). If the T cells do recognize self-anti-
gen in the periphery, their differentiation into effector cells
should be prevented by numerous mechanisms of periph-
eral tolerance that operate when self-antigens are not pre-
sented in an appropriate immunogenic context (24, 25). A
breakdown in peripheral tolerance can occur when envi-
ronmental factors such as infectious agents alter presen-
tation of self-antigens or stimulate self-reactive T cells
through molecular mimicry (26). This leads to the final step
in which differentiated, autoreactive T cells enter periph-
eral tissues and respond to antigen presented in situ. Op-
posing this step are regulatory T cells that appear to play a
critical role in preventing autoimmune disease (these cells
may act during the priming step as well) (27).
Given this perspective on the development of autoim-
mune disease, what are the predicted consequences of hav-
ing a large pool of nontolerant, PLP-specific T cells in the
periphery? Anderson et al. suggest that the increased num-
ber of peripheral PLP-specific T cells enhances disease sus-
ceptibility in SJL and Balb.S mice, presumably by increas-
ing the chances of priming PLP-specific T cells. Although a
high precursor frequency may increase susceptibility to
EAE, it is clearly not the only factor. There are enough
PLP-specific T cells in the lymph nodes of B10.S mice to
be able to detect a proliferative response to PLP in vitro
without prior immunization, yet this strain is fairly resistant
to EAE induction. The high precursor frequency of PLP
139–151-specific T cells in SJL mice is also not sufficient to
cause spontaneous disease. It is important to remember,
however, that laboratory mice live in a controlled environ-
ment with significantly less exposure to environmental
stimuli than they would encounter if they lived in the wild.
Therefore, if a similarly large increase in peripheral PLP-
specific T cells occurred in a subset of people, this factor
combined with environmental influences may be sufficient
to trigger multiple sclerosis (MS). If the analogy between
SJL mice and humans holds, it would suggest that HLA
molecules associated with susceptibility to MS would bind
with low or moderate affinity to epitopes of PLP or MBP
that are not represented in the isoforms of these proteins
expressed at higher levels in the thymus.
In contrast to wild-type SJL mice, a very high incidence
of spontaneous EAE is observed in PLP 139–151-specific
TCR–transgenic mice on the SJL background (28). One
explanation for the spontaneous EAE that occurs in the
TCR-transgenic mice is that many more PLP-specific T
cells are available to encounter environmental triggers and 
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differentiate into effector T cells. As tissue destruction me-
diated by a small number of T cells begins, the amount of
self-antigen released into the bloodstream is increased. An
increase in the concentration of self-antigen may fuel prim-
ing of more PLP-specific T cells in the periphery until con-
tinuing along the path toward autoimmunity becomes in-
evitable.
Spontaneous EAE is also observed in MBP 1–11 TCR–
transgenic mice. Different MBP 1–11 TCR–transgenic
models exhibit different incidences of disease, even though
the antigen specificity of the TCRs used in these models is
the same. Mice described by Goverman et al. exhibit a
higher incidence of spontaneous EAE than mice described
by Lafaille et al. when both types of transgenic mice are
backcrossed onto B10.PL and cohoused in the same en-
vironment (29–31). MBP 1–11-specific TCR–transgenic
mice described by Liu et al. (32) do not exhibit any sponta-
neous EAE. It is possible that different degrees of allelic ex-
clusion or differences in copy number of the transgenes in
these transgenic models affect the precursor frequency of
MBP 1–11-specific T cells in the periphery.
Although changes in precursor frequency of self-reactive
T cells no doubt contribute to susceptibility to autoimmune
disease, the abundance of regulatory T cells may be the crit-
ical factor in determining whether the pathway toward au-
toimmune disease is completed. Regulatory cells play a key
role in preventing autoimmune disease in MBP 1–11
TCR–transgenic mice. The incidence of EAE increases
dramatically when MBP-specific TCR–transgenic mice are
bred onto backgrounds in which regulatory T cells are
eliminated by preventing expression of endogenous TCRs
(30, 33, 34). Thus, the differences in susceptibility of the
various MBP 1–11 TCR–transgenic models to spontaneous
EAE could be explained by a larger or more effective pool
of regulatory cells in some models versus others. Similarly,
the spontaneous EAE observed in PLP 139–150 TCR–
transgenic mice may not be caused by an increase in PLP-
specific T cells above a critical threshold, but rather because
the restricted TCR repertoire in the transgenic mice limits
the number of regulatory T cells available to suppress the
autoreactive responses.
The picture that emerges from these studies is that au-
toimmune disease susceptibility reflects in part the ability of
particular MHC molecules to present selected epitopes of
self-antigens that are not synthesized in the thymus. Self-
antigen epitopes that contribute to autoimmune disease also
must not form such stable peptide–MHC complexes that
they either induce peripheral tolerance or are retained on
APCs migrating into the thymus from the periphery. These
self-reactive, nontolerant T cells that escape central toler-
ance are balanced in the periphery between a state of igno-
rance and autoimmunity. The factors that tip this balance
toward autoimmunity are most likely environmental factors
that trigger priming of the T cells in the periphery. The ef-
fectiveness of regulatory cells pushes the balance back to-
ward a state of ignorance. This balance becomes more diffi-
cult to maintain as the pool of autoreactive T cells increases.
A large number of autoreactive T cells increases the likeli-
hood that some of these T cells will be affected by environ-
mental influences such that more regulatory T cells are re-
quired to inhibit these responses. Circumstances that either
increase the number of nontolerant, self-reactive T cells
and/or decrease the number of regulatory cells will lower
the threshold required for induction of autoimmunity (Fig.
1). How the regulatory T cells that prevent autoimmunity
are themselves regulated is one of the most important areas
of future research in autoimmunity.
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